Wikipedia -WSS

Wikipedia

author：focus 2025-09-03 05:24:59 - browse：254

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Intercept Pharmaceuticals sells itself for less than $1 billion

focus

WSS

Texas Medical Board asked to define abortion emergency exception

Inequities make cancer less preventable for women: report

Shingles, which affected Dianne Feinstein, is on the rise

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Ionis has late

How the Dana

explore

Wikipedia

focus

Alkermes shareholders re

Sudafed saga points to U.S. issues with evaluating older drugs

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicaid, Medicare dual

In Memoriam: Notable people who died in 2023

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Hepatitis C has a cure — but many Americans still lack access to it

Medicaid, Medicare dual

Medicare proposal to cover medical devices draws a mixed reaction

Health tech startups drop sharply from 2021 highs

hotspot

Sudafed saga points to U.S. issues with evaluating older drugs

How one patient went off dialysis — and others can too

WHO recommends dropping component of many flu vaccines

Global cancer cases to surge 77% by 2050, WHO report says

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Why do women spend more than men on medical expenses?

explore

focus

hotspot

explore